FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2142985026> ?p ?o ?g. }

• W2142985026 endingPage "386" @default.
• W2142985026 startingPage "379" @default.
• W2142985026 abstract "The aim of this study was to evaluate whether multiaxial analysis of diabetes-specific biomechanical changes generated in vitro by non-enzymatic glycation of human skin samples from healthy subjects reflect the changes seen in skin from subjects with diabetes mellitus.Descriptive study.Non-enzymatic glycation of skin in vitro causes an increased stiffness comparable to in vivo changes seen in diabetic patients. These changes are probably due to increased cross-linking of collagen molecules.Skin specimens from 7 subjects with diabetes mellitus and 7 controls (age range: 74-90) were analyzed for biomechanical changes using a multiaxial tensile testing device. Control skins from healthy individuals in the age range of 50-65 yr were artificially glycated. One part of these samples was coincubated with the glycation inhibitor aminoguanidine. Glycation of tissues was determined by measuring fluorescence of solubilized samples. Multiaxial biomechanical analysis allows the determination of maximum (a(I)) and minimum elastic modulus (a(II)). These parameters describe the amplitude of the elastic stress response, which is exponentially related to strain.Principal stresses, both maximum and minimum, were increased in skins from diabetic subjects as compared to controls. The increases of the principal stresses were comparable to those obtained by in vitro glycation of normal skins.These results, which can be detected unequivocally with the multiaxial test mode, show that our in vitro model closely reflects changes in skin samples from individuals with diabetes mellitus. Aminoguanidine partially inhibited these as well as biochemical changes.Multiaxial testing of in vitro glycated skin samples can be used as a model for in vivo changes caused by diabetes mellitus. In addition, therapeutical effects of aminoguanidine, an inhibitor of non-enzymatic glycation, can be monitored in this model." @default.
• W2142985026 created "2016-06-24" @default.
• W2142985026 creator A5007646766 @default.
• W2142985026 creator A5024002767 @default.
• W2142985026 creator A5024782977 @default.
• W2142985026 creator A5089090852 @default.
• W2142985026 date "2000-06-01" @default.
• W2142985026 modified "2023-10-11" @default.
• W2142985026 title "Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation" @default.
• W2142985026 cites W125194288 @default.
• W2142985026 cites W1975856506 @default.
• W2142985026 cites W1976068063 @default.
• W2142985026 cites W1976236115 @default.
• W2142985026 cites W1987380694 @default.
• W2142985026 cites W1991592077 @default.
• W2142985026 cites W1993736540 @default.
• W2142985026 cites W1996757319 @default.
• W2142985026 cites W2012851241 @default.
• W2142985026 cites W2013962258 @default.
• W2142985026 cites W2016475405 @default.
• W2142985026 cites W2026445864 @default.
• W2142985026 cites W2026703782 @default.
• W2142985026 cites W2043397658 @default.
• W2142985026 cites W2053220689 @default.
• W2142985026 cites W2053324630 @default.
• W2142985026 cites W2066824114 @default.
• W2142985026 cites W2068793587 @default.
• W2142985026 cites W2071231074 @default.
• W2142985026 cites W2075800553 @default.
• W2142985026 cites W2077723344 @default.
• W2142985026 cites W2080904568 @default.
• W2142985026 cites W2084126217 @default.
• W2142985026 cites W2088844252 @default.
• W2142985026 cites W2095031585 @default.
• W2142985026 cites W2107463204 @default.
• W2142985026 cites W2120155566 @default.
• W2142985026 cites W2146720467 @default.
• W2142985026 cites W2147789746 @default.
• W2142985026 cites W2148729578 @default.
• W2142985026 cites W2333705594 @default.
• W2142985026 cites W2337292567 @default.
• W2142985026 cites W2502255954 @default.
• W2142985026 cites W4239336343 @default.
• W2142985026 cites W4239419678 @default.
• W2142985026 cites W4245276687 @default.
• W2142985026 cites W4254523290 @default.
• W2142985026 cites W4292495111 @default.
• W2142985026 doi "https://doi.org/10.1016/s0268-0033(99)00085-6" @default.
• W2142985026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10758300" @default.
• W2142985026 hasPublicationYear "2000" @default.
• W2142985026 type Work @default.
• W2142985026 sameAs 2142985026 @default.
• W2142985026 citedByCount "49" @default.
• W2142985026 countsByYear W21429850262012 @default.
• W2142985026 countsByYear W21429850262013 @default.
• W2142985026 countsByYear W21429850262014 @default.
• W2142985026 countsByYear W21429850262015 @default.
• W2142985026 countsByYear W21429850262016 @default.
• W2142985026 countsByYear W21429850262017 @default.
• W2142985026 countsByYear W21429850262018 @default.
• W2142985026 countsByYear W21429850262019 @default.
• W2142985026 countsByYear W21429850262020 @default.
• W2142985026 countsByYear W21429850262022 @default.
• W2142985026 crossrefType "journal-article" @default.
• W2142985026 hasAuthorship W2142985026A5007646766 @default.
• W2142985026 hasAuthorship W2142985026A5024002767 @default.
• W2142985026 hasAuthorship W2142985026A5024782977 @default.
• W2142985026 hasAuthorship W2142985026A5089090852 @default.
• W2142985026 hasConcept C126322002 @default.
• W2142985026 hasConcept C134018914 @default.
• W2142985026 hasConcept C147990577 @default.
• W2142985026 hasConcept C150903083 @default.
• W2142985026 hasConcept C185592680 @default.
• W2142985026 hasConcept C192562407 @default.
• W2142985026 hasConcept C202751555 @default.
• W2142985026 hasConcept C207001950 @default.
• W2142985026 hasConcept C55493867 @default.
• W2142985026 hasConcept C555293320 @default.
• W2142985026 hasConcept C71924100 @default.
• W2142985026 hasConcept C86803240 @default.
• W2142985026 hasConceptScore W2142985026C126322002 @default.
• W2142985026 hasConceptScore W2142985026C134018914 @default.
• W2142985026 hasConceptScore W2142985026C147990577 @default.
• W2142985026 hasConceptScore W2142985026C150903083 @default.
• W2142985026 hasConceptScore W2142985026C185592680 @default.
• W2142985026 hasConceptScore W2142985026C192562407 @default.
• W2142985026 hasConceptScore W2142985026C202751555 @default.
• W2142985026 hasConceptScore W2142985026C207001950 @default.
• W2142985026 hasConceptScore W2142985026C55493867 @default.
• W2142985026 hasConceptScore W2142985026C555293320 @default.
• W2142985026 hasConceptScore W2142985026C71924100 @default.
• W2142985026 hasConceptScore W2142985026C86803240 @default.
• W2142985026 hasIssue "5" @default.
• W2142985026 hasLocation W21429850261 @default.
• W2142985026 hasLocation W21429850262 @default.
• W2142985026 hasOpenAccess W2142985026 @default.
• W2142985026 hasPrimaryLocation W21429850261 @default.
• W2142985026 hasRelatedWork W1566729005 @default.

• next